About Questcor - Questcor Pharmaceuticals, Inc.® (AMEX:QSC - News) is a specialty pharmaceutical company that develops and sells therapeutics for the treatment of neurological disorders. Questcor currently owns H.P. Acthar® Gel (repository corticotropin injection), an injectable drug indicated for the treatment of exacerbations associated with Multiple Sclerosis and Doral® (quazepam) that is indicated for the treatment of insomnia, characterized by difficulty in falling asleep, frequent nocturnal awakenings, and/or early morning awakenings. For more information, please visit www.questcor.com.

Contact Information

3260 Whipple Road
Union City, CA 94587

tel: 510-400-0700
fax: 510-400-0799


Investor Relations



Exchange: AMEX
Industry: Biotechnology
Market Cap: $280.4M

The information provided here has been obtained from publicly available sources as well as directly from issuers in some cases. Please see our Disclaimer and Terms of Service for more information.